Monopar Therapeutics
MNPR
MNPR
16 hedge funds and large institutions have $268K invested in Monopar Therapeutics in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$111K | |
| 2 | +$21K | |
| 3 | +$3.75K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.88K |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$2.04K |
Top Sellers
| 1 | -$16K | |
| 2 | -$6.35K | |
| 3 | -$4.87K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.74K |
| 5 |
VF
Virtu Financial
New York
|
-$2.25K |